OS Therapies (OSTX) Dividends payables (2023 - 2026)
OS Therapies' (OSTX) quarterly Dividends payables came in at $375000.0 in Q1 2026, little changed YoY from $375000.0 in Q1 2025, and little changed on a QoQ basis from $375000.0 in Q4 2025.
OS Therapies (OSTX) Dividends payables (2023 - 2026) Analysis & Trends
OS Therapies (OSTX) has 4 years of Dividends payables data on file, last reported at $375000.0 in Q1 2026.
- Quarterly Dividends payables changed 0.0% year-over-year to $375000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $375000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $375000.0, changed 0.0% from the prior year.
- Dividends payables held at $375000.0 in Q1 2026, from $375000.0 in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $375000.0 in Q1 2024 to a low of $31250.0 in Q1 2023.
- A 4-year average of $340909.1 and a median of $375000.0 in 2024 frame the typical range for Dividends payables.
- Annual changes were most pronounced in 2024 — Dividends payables soared 1100.0% — and 2025, when it changed 0.0%.
- Tracing OSTX's Dividends payables over 4 years: stood at $343750.0 in 2023, then increased by 9.09% to $375000.0 in 2024, then changed by 0.0% to $375000.0 in 2025, then changed by 0.0% to $375000.0 in 2026.
- The last three Dividends payables figures came in at $375000.0 (Q1 2026), $375000.0 (Q4 2025), and $375000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | OS Therapies | 19.31 Mn | 19.31 Mn | - | 375,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | 375,000.00 |
| Mar 31, 2025 | 375,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Sep 30, 2024 | 375,000.00 |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | 375,000.00 |
| Dec 31, 2023 | 343,750.00 |
| Mar 31, 2023 | 31,250.00 |